Soyoung Park

Soyoung is passionate to help founders achieve their vision and positively impact the world to improve human well-being and quality of life. By leveraging healthcare innovation, financial analysis, and business development expertise to invest in and support entrepreneurs in solving the most pressing challenges. She also mentors aspiring entrepreneurs through various organizations, specializing in managing early-stage startup strategies and executing profit maximization projects. Prior to venture investment, Soyoung had co-led four post-acquisition integrations in medtech, biotech, and clenatech in the US, including an acquisiiton by Pfizer at $5.4B in 2022. She holds an MBA degree at The Fuqua Business School, Duke University, concentrated on the Health Sector Managements.